Physician profile
Eric Yates
NPI 1457770109
$1,665.36
in general payments reported to CMS, 2019-2025
9 companies · $536 in 2025
The $536 reported for 2025 was more than what 93% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.81 · 2020: $219 · 2021: $205 · 2022: $191 · 2023: $174 · 2024: $321 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $356.73 | 2019-2024 | Xarelto |
| Abbvie INC. | $291.86 | 2023-2024 | Dalvance |
| Boston Scientific Corporation | $254.68 | 2022-2025 | Enroute Transcarotid Neuroprotection System |
| Stryker Corporation | $247.80 | 2025 | Artix Mt |
| Ceribell, INC. | $177.28 | 2025 | Pocket Eeg Device |
| Novo Nordisk INC | $125.01 | 2020 | |
| Chiesi USA, INC. | $124.17 | 2024 | Cleviprex |
| Pfizer INC. | $74.30 | 2021 | |
| Irhythm Technologies, INC. | $13.53 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Yates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.